Skip to main content
Log in

Polymorphism of Nicotinamide Riboside Chloride and Crystal Structure Determination of the Most Stable Crystalline Form

  • Original Paper
  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

Three crystalline forms of nicotinamide riboside chloride (NR-Cl), namely Form A, Form B and Form C, were prepared and characterized. Form A and Form B are true polymorphs of anhydrous forms, while Form C is a pseudo-polymorph of a methanolate solvate form. The relative polymorphic stability relationship among these three crystalline forms was established, and Form B was found to be the most stable form with a higher crystal density (1.591 Mg/m3) and a higher melting/decomposing temperature (123 °C) compared to that of Form A (1.512 Mg/m3 and 119 °C). The crystal structure of Form B (orthorhombic P212121 space group, a = 7.0008(11) Å, b = 9.6465(15) Å, c = 17.971(3) Å, V = 1213.7(3) Å3, Z = 4) was determined by single crystal X-ray diffraction analysis.

Index Abstract

The crystal structure of the most stable polymorph of nicotinamide riboside chloride (NR-Cl) is reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

All data generated or analyzed for this work are included in the article and the Supplementary Information document. CCDC number 2,244,277 contains the crystallographic data for NR-Cl-Form B reported in this paper. These data can be obtained free of charge via www.ccdc.cam.ac.ukldata-request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax:+44 1223 336,033.

References

  1. Chi Y, Sauve AA (2013) Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Curr Opin Clin Nutr Metab Care 16(6):657–661. https://doi.org/10.1097/MCO.0b013e32836510c0

    Article  CAS  PubMed  Google Scholar 

  2. Martens CR, Denman BA, Mazzo MR et al (2018) Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD + in healthy middle-aged and older adults. Nat Commun 9:1286. https://doi.org/10.1038/s41467-018-03421-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mehmel M, Jovanovic N, Spitz U (2020) Nicotinamide Riboside—The current state of Research and Therapeutic uses. Nutrients 12(6):1616. https://doi.org/10.3390/nu12061616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Szczepankiewicz B, Koppetsch K, Perni RB (2015) Preparation and use of crystalline beta-d-nicotinamide riboside. GlaxoSmithKline, p WO2015186068

  5. Carlson EC, Standen MC, Morrill WM (2016) Crystalline form of nicotinamide riboside. W. R. Grace & Co. WO2016014927

  6. Carlson EC, Osuna J (2016) Crystalline form of nicotinamide riboside. W. R. Grace & Co. WO2016144660

  7. Migaud ME, Redpath P, Crossey K, Cunningham R, Ericksonl A, Nygaard R, Storjohann A (2018) Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof. The Queen’s University and ChromaDex Inc. WO2018089830

  8. Marcotulli E, Alminana D, Dellinger R, Morris M (2019) Crystalline forms of nicotinamide riboside chloride. Elysium Health, Inc., p WO2019126482

  9. Zhou WF, Zhang ZY, Xie ZY, Wu YC, Shi X, Wang H, Zhu WC, Chen SY (2020) Beta-nicotinamide riboside chloride crystal form 1A and crystal form 1B and preparation method thereof. Xuchang Yuanzhi Biotechnology Co ltd, p CN111808156

  10. Alvarez R, Schabert G, Soydemir A, Wick L, Spitz U, Spingler B (2019) Nicotinamide Riboside derivatives: single crystal growth and determination of X-ray structures. Cryst Growth Des 19(7):4019–4028. https://doi.org/10.1021/acs.cgd.9b00423

    Article  CAS  Google Scholar 

  11. Campbell MTD, Jones DS, Andrews GP, Li S (2019) Understanding the physicochemical properties and degradation kinetics of nicotinamide riboside, a promising vitamin B3 nutritional supplement. Food Nutr Res 63:3419. https://doi.org/10.29219/fnr.v63.3419

    Article  CAS  Google Scholar 

  12. Schabert G, Haase R, Parris J, Pala L, Hery-Barranco A, Spingler B, Spitz U (2021) New Crystalline Salts of Nicotinamide Riboside as Food additives. Molecules 26(9):2729. https://doi.org/10.3390/molecules26092729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zarei A, Khazdooz L, Madarshahian S, Enayati M, Mosleh I, Lin T, Yan B, Ufheil G, Wooster TJ, Abbaspourrad A (2022) Synthesis, Stability, and bioavailability of Nicotinamide Riboside Trioleate Chloride. Nutrients 14(1):113. https://doi.org/10.3390/nu14010113

    Article  CAS  Google Scholar 

  14. Nadeeshani H, Li JY, Ying TL, Zhang BH, Lu J (2022) Nicotinamide mononucleotide (NMN) as an anti-aging health product - promises and safety concerns. J Adv Res 37:267–278. https://doi.org/10.1016/j.jare.2021.08.003

    Article  CAS  PubMed  Google Scholar 

  15. Sheldrick GM (1997) SHELXL-97, Program for the refinement of Crystal Structures. University of Göttingen, Göttingen (Germany)

    Google Scholar 

  16. Macrae CF, Sovago I, Cottrell SJ, Galek PTA, McCabe P, Pidcock E, Platings M, Shields GP, Stevens JS, Towler M, Wood PA (2020) Mercury 4.0: from visualization to analysis, design and prediction. J Appl Cryst 53:226–235. https://doi.org/10.1107/S1600576719014092

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Faraj Atassi, Dr. Steve Cook and Dr. Liping Zhou in AstraZeneca for invaluable discussions and proof reading of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Dedong Wu wrote the main manuscript text and carried out the polymorph study; Branden Wu prepared the crystals for single crystal analysis; Pingrong Wei collected single crystal x-ray diffraction data and verified the crystal structure. All authors reviewed the manuscript.

Corresponding author

Correspondence to Dedong Wu.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare that are relevant to the content of this paper.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, D., Wu, B. & Wei, P. Polymorphism of Nicotinamide Riboside Chloride and Crystal Structure Determination of the Most Stable Crystalline Form. J Chem Crystallogr 53, 465–474 (2023). https://doi.org/10.1007/s10870-023-00985-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10870-023-00985-1

Keywords

Navigation